Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Lesokhin AM"'
Autor:
Lesokhin, AM, Arnulf, B, Niesvizky, R, Mohty, M, Bahlis, NJ, Tomasson, MH, Rodrguez-Otero, P, Quach, H, Raje, NS, Iida, S, Raab, M, Czibere, A, Sullivan, S, Leip, E, Viqueira, A, Blunk, V, Leleu, X
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2022 44 Supplement 2:S245-S246
Autor:
Solh, M, Bahlis, NJ, Raje, NS, Costello, CL, Dholaria, B, Levy, MY, Tomasson, MH, Dube, H, Damore, MA, Lon, HK, Basu, C, Skoura, A, Chan, EM, Trudel, S, Jakubowiak, A, Chu, MP, Gasparetto, C, Dalovisio, A, Sebag, M, Lesokhin, AM
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2021 43 Supplement 1:S195-S196
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Richard S; Tisch Cancer Institute, Icahn School of Medicine, New York, NY, USA., Lesokhin AM; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Paul B; Levine Cancer Institute, Charlotte, NC, USA., Kaufman JL; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Pianko M; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA., Biran N; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA., Vij R; Washington University School of Medicine, St. Louis, MO, USA., Doxie DB; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Azeem MI; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Martillo M; The Multiple Myeloma Research Foundation, Norwalk, CT, USA., Wozniak K; The Multiple Myeloma Research Foundation, Norwalk, CT, USA., Cho HJ; Tisch Cancer Institute, Icahn School of Medicine, New York, NY, USA.; The Multiple Myeloma Research Foundation, Norwalk, CT, USA., Dhodapkar KM; Winship Cancer Institute, Emory University, Atlanta, GA, USA. kavita.dhodapkar@emory.edu.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Department of Pediatric Hematology/Oncology, Emory University, Atlanta, GA, USA. kavita.dhodapkar@emory.edu., Dhodapkar MV; Winship Cancer Institute, Emory University, Atlanta, GA, USA. madhav.v.dhodapkar@emory.edu.
Publikováno v:
Nature cancer [Nat Cancer] 2024 Oct; Vol. 5 (10), pp. 1459-1464. Date of Electronic Publication: 2024 Aug 26.
Autor:
Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. hultcram@mskcc.org., Hassoun H; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Korde N; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., MacLachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mailankody S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Patel D; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shah UA; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tan CR; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chung DJ; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lahoud OB; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Landau HJ; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Scordo M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shah GL; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Giralt SA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pianko MJ; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Burge M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Barnett K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Salcedo M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Caple J; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tran L; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Blaslov J; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shekarkhand T; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hamid S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nemirovsky D; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Derkach A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Arisa O; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Peer CJ; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Figg WD; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Usmani SZ; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Lesokhin AM; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Sep 19; Vol. 14 (1), pp. 164. Date of Electronic Publication: 2024 Sep 19.
Autor:
Maura F, Kaddoura M, Poos AM, Baughn LB, Ziccheddu B, Bärtsch MA, Cirrincione A, Maclachlan K, Chojnacka M, Diamond B, Papadimitriou M, Blaney P, John L, Reichert P, Huhn S, Gagler D, Zhang Y, Dogan A, Lesokhin AM, Davies F, Goldschmidt H, Fenk R, Weisel KC, Mai EK, Korde N, Morgan GJ, Rajkumar SV, Kumar S, Usmani S, Landgren O, Raab MS, Weinhold N
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Sep 04. Date of Electronic Publication: 2024 Sep 04.
Autor:
Cirrincione AM; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Poos AM; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Ziccheddu B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Kaddoura M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Bärtsch MA; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Maclachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Chojnacka M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Diamond B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., John L; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Reichert P; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Huhn S; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Blaney P; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Gagler D; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Rippe K; Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany., Zhang Y; Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Dogan A; Hematopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Lesokhin AM; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Davies F; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Goldschmidt H; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany., Weisel KC; Department of Oncology, Hematology, and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mai EK; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Korde N; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Morgan GJ; Myeloma Research Program, New York University Langone, Perlmutter Cancer Center, New York, NY., Usmani S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Raab MS; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Weinhold N; Heidelberg Myeloma Center, Department of Medicine V, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany., Maura F; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.
Publikováno v:
Blood [Blood] 2024 Aug 15; Vol. 144 (7), pp. 771-783.
Autor:
Firestone RS; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Socci ND; Department of Engineering and Bioinformatics, Memorial Sloan Kettering Cancer Center, New York, NY., Shekarkhand T; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Zhu M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Qin WG; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Mailankody S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Tan CR; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Korde N; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Lesokhin AM; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Hassoun H; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Shah U; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Maclachlan KH; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Rajeeve S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Landau HJ; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Scordo M; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Shah GL; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Lahoud OB; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Giralt S; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Murata K; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Usmani SZ; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Chung DJ; Department of Medicine, Weill Cornell Medical College, New York, NY.; Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v:
Blood [Blood] 2024 Jul 25; Vol. 144 (4), pp. 402-407.
Autor:
Tomasson MH; Department of Internal Medicine University of Iowa Iowa City Iowa USA., Iida S; Department of Hematology & Oncology Nagoya City University Graduate School of Medical Sciences Nagoya Japan., Niesvizky R; Multiple Myeloma Center New York-Presbyterian Hospital/Weill Cornell Medical Center New York New York USA., Mohty M; Hematology and Cellular Therapy Department Sorbonne University, Hôpital Saint-Antoine and INSERM UMRS938 Paris France., Bahlis NJ; Division of Hematology and Bone Marrow Transplantation, Arnie Charbonneau Cancer Institute University of Calgary Calgary Alberta Canada., Martinez-Lopez J; Haematology and Haemotherapy Service Hospital Universitario 12 de Octubre, Complutense University of Madrid, Centro Nacional de Investigaciones Oncológicas, Instituto de Investigación Hospital 12 de Octubre Madrid Spain., Koehne G; Blood & Marrow Transplant and Hematologic Oncology Miami Cancer Institute Miami Florida USA., Rodriguez-Otero P; Central Unit for Clinical Trials Clinica Universidad de Navarra Madrid Spain., Miles Prince H; Cancer Immunology and Molecular Oncology Epworth Healthcare and University of Melbourne Melbourne Victoria Australia., Viqueira A; Oncology Research and Development Pfizer SLU Madrid Spain., Leip E; Department of Clinical Research Pfizer Inc. Cambridge Massachusetts USA., Conte U; Oncology Research and Development Pfizer Inc. New York New York USA., Sullivan ST; Global Product Development Pfizer Inc. Cambridge Massachusetts USA., Lesokhin AM; Division of Hematology and Oncology Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College New York New York USA.
Publikováno v:
HemaSphere [Hemasphere] 2024 Jul 24; Vol. 8 (7), pp. e136. Date of Electronic Publication: 2024 Jul 24 (Print Publication: 2024).